ETARTILEN 1.5 mg/ml, eye drop solution 20 single-dose containers of 0.3 ml
Active ingredients: Dexamethasone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution20 single-dose containers of 0.3 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ETARTILEN 1,5 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 20 récipients unidoses polyéthylène basse densité (PEBD) suremballés/surpochés aluminium de 0,3 mL
- Marketing authorisation holder
- SIFI (ITALIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Aug 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63915157CIP73018866CIP133400930188668Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE SODIQUE DE DEXAMÉTHASONEcollyre | 1,5 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.